# Contribution of Inflammation and Neuronal Integrity Markers in Patients With First-episode Conversive Motor Disorder

> **NCT05305014** · — · COMPLETED · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 20 (actual)

## Conditions studied

- Conversion Disorder

## Interventions

- **DIAGNOSTIC_TEST:** blood inflammatory markers (TNF-α, IL1ra, RsIL-2, IL-6, IL-10, IL-18, IFNγ, MCP-1/CCL2 GFAP)

## Key facts

- **NCT ID:** NCT05305014
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-01
- **Primary completion:** 2022-04-15
- **Final completion:** 2022-04-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05305014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05305014, "Contribution of Inflammation and Neuronal Integrity Markers in Patients With First-episode Conversive Motor Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05305014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*